Matritech (NASDAQ - NMPS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Matritech (NASDAQ - NMPS)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John McCarthy who wrote (492)	10/3/1997 10:40:00 AM
From: William J. Leiby	of 849

John: Yeah, not sure how the cervical goes against the competitors. The one area missed is the fact that the co. has two prostate NMPs. One can detect cancer from benign prostatic hypertrophy (the PSA cannot do this) - I've read the PSA's market is 200 mil. The other NMP can detect fast growing tumors from the slow ones. These are due to go to clinical trials in early 98. The breast cancer is the one I'm excited about. As you pointed out, this test detects the cancer much earlier than any standard procedure. Regards, Bill

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next